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management of Cushing's disease while
waiting for pituitary irradiation to become
effective and, in particular, the use ofbromo-
criptine to manage patients with functional
hyperprolactinaemia or prolactin-secreting
microadenomas, is barely mentioned. The
book is primarily for the neurosurgeon, but it
does contain a great deal ofmaterial that will
interest the endocrinologist. The contribu-
tions are well written and the book is well
produced with excellent illustrations. It can
be recommended.
S. M. SHALET
Progress in Radiopharmacology, Vol. 1.
(Ed.) P. H. Cox (1979) Amsterdam:
Elsevier North-Holland. 250 pp. 85 Dfl.
This book contains the papers presented at
the European Symposium on Radiopharma-
cology, held at Noordwijkerhout, The Nether-
lands, inJune 1979.
Twenty papers were presented, 19 from
different centres in Europe and 1 from the
U.S.A. The subjects discussed are: 1-Ionic
tumour-seeking radiopharmaceuticals, 2-
Technetium-labelled skeletal reagents, 3-
TechnetiumIDAderivatives forliver-function
studies.
Each session reviewed the radiochemical
and biological behaviour of the compounds
inrelation tothe physiopathology ofthe organ
or tissue under study, followed by discussion
of the clinical value of these different com-
pounds.
The book is well presented, directly from
typescript, and a good standard is kept
throughout the chapters.
In summary, this is a useful book which
gives a good review of these aspects of radio-
pharmacology, and we look forward to a fur-
ther publication containing new topics of
radiopharmacology.
H. T. TESTA
BCG Vaccine: Tuberculosis-Cancer.
S. R. ROSENTHAL (1980) Littleton, Massa-
chusetts: P.S.G. 410 pp. $25-00.
This is primarily a book on bacteriology,
rather than immunology or oncology, but
nevertheless will also be of value to anyone
interested in the vaccine which has attracted
the attention of immunologists and oncolo-
gists for so long. It describes, with extensive
references, thenature ofthe complex organism
which has been known by the deceptively
simple title of "BCG". Its origin, nearly 60
years ago, its culture and biochemical charac-
teristics and how it is handled, freeze-dried or
preserved as viable vaccine for clinical use,
are described in detail. The strain of BCG,
and how it is cultured and freeze-dried, can
dramatically influence its virulence and
viability, and the immunizing potency of the
final vaccine, and this is stressed throughout.
An account is also given ofthe techniques for
the several routes of administration of BCG
used in both tuberculosis immunization and
tumour immunotherapy, and adverse reac-
tions sometimes associated with them. The
one chapter on BCG in cancer and leukaemia
outlines briefly the clinical experience with
BCG and emphasizes that variable effects of
BCG in different trials may well be associated
with the use of different strains and prepara-
tions. More recently, of course, BCG sub-
cellular components, such as cord factor and
muramyl dipeptide and synthetic analogues,
have superseded BCG to a large extent for
immunological purposes, though these are
outside the scope ofthis book and only briefly
mentioned. In this context, it is a pity that
this volume was not available a few years ago
when BCG itself was attracting such great
attention for immunotherapy trials, but even
now it will be of value to anyone interested
in the biological effects of this fascinating
organism.
M. V. PIMM
Contemporary Hematology/Oncology.
(Eds) J. LoBuE, A. S. GORDON, R. SILBER
& F. M. MUGGIA (1980) New York: Plenum.
330 pp. £29-50.
This book is the successor to "The Year
in Hematology" produced by the same team.
The new title, it seems, was suggested by a
reader who pointed out to the editors that
the original implied that only advances made
during the year under review were included.
In fact, the papers in each of the 3 volumes
so far published explore theoretical concepts
and experimental work which have gradually
evolved over a longer time scale. The editors
then invite distinguished contributors to
review a subject of current practical impor-
tance in the investigation and treatment of
blood diseases.